CIBC Private Wealth Group, LLC
- SEC CIK
- 0001298088
- Latest filing
- Feb 12, 2026
NBIX holding history
Neurocrine Biosciences Inc in every 13F filed by CIBC Private Wealth Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBIX overviewAll 13F holders of NBIXFull Q4 2025 holdings
- Shares (Q4 2025)
- 7,726
- Value
- $1.10M
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 7,726 | $1.10M | <0.1% | −255−3.2% | Reduced | Holders |
| Q3 2025 | 7,981 | $1.12M | <0.1% | +7,935+17,250.0% | Added | Holders |
| Q2 2025 | 46 | $5.78K | <0.1% | −13−22.0% | Reduced | Holders |
| Q1 2025 | 59 | $5.17K | <0.1% | −986−94.4% | Reduced | Holders |
| Q4 2024 | 1,045 | $145.0K | <0.1% | −107−9.3% | Reduced | Holders |
| Q3 2024 | 1,152 | $132.7K | <0.1% | −3−0.3% | Reduced | Holders |
| Q2 2024 | 1,155 | $164.3K | <0.1% | −6,472−84.9% | Reduced | Holders |
| Q1 2024 | 7,627 | $1.08M | <0.1% | +7,627 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −24,925−100.0% | Sold out | Holders |
| Q4 2022 | 24,925 | $2.98K | <0.1% | +3,846+18.2% | Added | Holders |
| Q3 2022 | 21,079 | $2.24M | <0.1% | +21,079 | New | Holders |